Thus, there is no apparent link between the percentage of HLA-G-positive tumour samples and the subsequent verdict on the association between HLA-G expression and clinical outcome of pancreatic carcinoma patients. This evidence concerns the gene HLA-G and exocrine pancreatic carcinoma.